Publishing research using ab661? Please let us know so that we can cite the reference in this datasheet.
ab661 has been referenced in 5 publications.
Kim JK et al.Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K.Cancer Invest 30:364-71 (2012).
Lee SM et al.Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.Clin Exp Immunol 167:438-46 (2012).
Shin JH et al.PARIS (ZNF746) repression of PGC-1a contributes to neurodegeneration in Parkinson's disease.Cell 144:689-702 (2011).
Lee SM et al.Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K.Immunology 134:224-33 (2011).
Lee SM et al.CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.J Immunol 186:6296-303 (2011).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up